EsoCap AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis (NCT04849390) | EsoCap AG | 2021-06-29 |
Track EsoCap AG automatically
Every clearance here is in the API, with alerts when new ones post.